跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hivent Ds - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hivent Ds
Approved
STANDARD
Hivent Ds
EURO-MED LABORATORIES PHIL., INC.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6cffa38bd33dcc15
Company
EURO-MED LABORATORIES PHIL., INC.
Type
Standard
Approval Details
Approval Id
6cffa38bd33dcc15
Drug Approval Philippines Name
Hivent Ds
Product Name
Hivent Ds
Registration Number
DR-XY28353
Brand Name
Hivent Ds
Generic Name
Salbutamol (As Sulfate) 2 Mg/Ml Solution For Nebulization
Dosage Form
Solution For Nebulization
Dosage Strength
Each mL contains 2 mg Salbutamol (as sulfate)
Manufacturer
EURO-MED LABORATORIES PHIL., INC.
Issuance Date
28 October 2022
Expiry Date
20 February 2028
Pharmacologic Category
Selective beta-2-adrenoreceptor agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6cffa38bd33dcc15
Type
Standard
Back to Philippines FDA Approvals